Some individuals then transition to lower maintenance doses or intermittent cycles, while others may stop therapy if lifestyle changes are sufficient to sustain balance
Likewise, Wegovy, the brand name, is an injectable semaglutide that the FDA approves for weight loss and can be dosed with or without food
Assessing the real-world effect of semaglutide and tirzepatide on weight loss provides a glimpse into what we may see with the recently approved obesity drug tirzepatide (brand name Zepbound) and how it might compare with semaglutide (brand name Wegovy)
Dong JZ, Shen Y, Zhang J, Tsomaia N, Mierke DF, Taylor JE
Approval status: Gonadorelin was FDA-approved historically as Factrel for diagnostic testing of pituitary gonadotropic function, and as Lutrepulse/Lutrelef delivered by pulsatile pump for hypothalamic amenorrhea
In the case of semaglutide, it's posited that the medication's effectiveness in reducing appetite and promoting weight loss could inadvertently lead to amenorrhea